Tumor-cell-derived microvesicles as carriers of molecular information in cancer

Current Opinion in Oncology

Volumn 25, Issue 1, 2013, Pages 66-75

  Martins, Vilma R ^a   Dias, Marcos S ^b   Hainaut, Pierre ^b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Biomarker; Cancer; Exosomes; Metabolism; Metastasis; Microvesicles

Indexed keywords

CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; CELL DIFFERENTIATION; CELL INTERACTION; CELL METABOLISM; CELL VACUOLE; CHEMICAL COMPOSITION; DENDRITIC CELL; EXOSOME; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; STROMA CELL; TUMOR CELL; TUMOR CELL DERIVED MICROVESICLE; TUMOR MICROENVIRONMENT;

ANIMALS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; EXOSOMES; EXTRACELLULAR SPACE; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84871960964     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32835b7c81     Document Type: Review

References (95)

1. Pavlou MP, Diamandis EP. The cancer cell secretome: A good source for discovering biomarkers? J Proteomics 2010; 73:1896-1906
2. Fader CM, Colombo MI. Multivesicular bodies and autophagy in erythrocyte maturation. Autophagy 2006; 2:122-125
3. Henderson MC, Azorsa DO. The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol 2012; 2:38
4. Lee TH, D'Asti E, Magnus N, et al. Microvesicles as mediators of intercellular communication in cancer - the emerging science of cellular 'debris'. Semin Immunopathol 2011; 33:455-467
5. Hendrix A, Hume AN. Exosome signaling in mammary gland development and cancer. Int J Dev Biol 2011; 55:879-887
6. Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for premetastatic niche formation: Old sayings and new thoughts. Semin Cancer Biol 2011; 21:139-146
7. Roberson CD, Atay S, Gercel-Taylor C, Taylor DD. Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers. Cancer Biomark 2010; 8:281-291
8. Mathivanan S, Ji H, Simpson RJ. Exosomes: Extracellular organelles important in intercellular communication. J Proteomics 2010; 73:1907-1920
9. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009; 10:148-155
10. Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol 2008; 20:4-11
11. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14:677-685
12. De Gassart A, Geminard C, Fevrier B, et al. Lipid raft-associated protein sorting in exosomes. Blood 2003; 102:4336-4344
13. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319:1244-1247
14. Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12:19- 30; sup pp. 1-13
15. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: Artefacts no more. Trends Cell Biol 2009; 19:43-51
16. Nabhan JF, Hu R, Oh RS, et al. Formation and release of arrestin domaincontaining protein 1-mediated microvesicles (ARMMs) at plasmamembrane by recruitment of TSG101 protein. Proc Natl Acad Sci USA 2012; 109:4146- 4151
17. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012; 40:D1241- D1244
18. Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284:34211-34222
19. Vickers KC, Remaley AT. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23:91-97
20. Van den Boorn JG, Dassler J, Coch C, et al. Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev 2012
21. Hu G, Drescher KM, Chen XM. Exosomal miRNAs: Biological properties and therapeutic potential. Front Genet 2012; 3:56
22. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659
23. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adhes Migr 2007; 1:156-158
24. Hong BS, Cho JH, Kim H, et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 2009; 10:556
25. Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nat Cell Biol 2012; 14:1036-1045
26. Tan A, De La Pena H, Seifalian AM. The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine 2010; 5:889-900
27. Taylor DD, Gercel-Taylor C. Exosomes/microvesicles: Mediators of cancerassociated immunosuppressive microenvironments. Semin Immunopathol 2011; 33:441-454
28. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9:581-593
29. Dolo V, D'Ascenzo S, Violini S, et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 1999; 17:131-140
30. Graves LE, Ariztia EV, Navari JR, et al. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004; 64:7045- 7049
31. McCready J, Sims J, Chan D, Jay D. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: A role for plasminogen activation. BMC Cancer 2010; 10:294
32. Koumangoye R, Sakwe A, Goodwin J, et al. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One 2011; 6:e6830-e6840
33. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005; 113:752-760
34. Svensson K, Kucharzewska P, Christianson H, et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2- mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci USA 2011; 108:13147-13152
35. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10:619-624
36. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-1476
37. Al-Nedawi K, Meehan B, Kerbel R, et al. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009; 106:3794-3799
38. Antonyak M, Li B, Boroughs L, et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 2011; 108:4852-4857
39. Sheldon H, Heikamp E, Turley H, et al. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010; 116:2385-2394
40. Qu J, Qu X, Zhao M, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis 2009; 41:875-880
41. Ristorcelli E, Beraud E, Mathieu S, et al. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int J Cancer 2009; 125:1016-1026
42. Ristorcelli E, Beraud E, Verrando P, et al. Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J 2008; 22:3358-3369
43. Soderberg A, Barral A, Soderstrom M, et al. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic Biol Med 2007; 43:90-99
44. Hood J, Pan H, Lanza G, Wickline S. Paracrine induction of endothelium by tumor exosomes. Lab Invest 2009; 89:1317-1328
45. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883-891
46. Ghosh A, Secreto C, Knox T, et al. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: Implications for disease progression. Blood 2010; 115:1755-1764
47. Zwicker J, Liebman H, Neuberg D, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15:6830-6840
48. Meckes DJ, Shair K, Marquitz A, et al. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA 2010; 107:20370- 20375
49. Higginbotham J, Demory Beckler M, Gephart J, et al. Amphiregulin exosomes increase cancer cell invasion. Curr Biol 2011; 21:779-786
50. Adamczyk K, Klein-Scory S, Tehrani M, et al. Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci 2011; 89:304-312
51. Graner M, Alzate O, Dechkovskaia A, et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 2009; 23:1541-1557
52. Ciravolo V, Huber V, Ghedini G, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 2012; 227:658-667
53. Cho J, Park H, Lim E, Lee K. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol 2012; 40:130-138
54. Zoller M. Tetraspanins: Push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9:40-55
55. Chairoungdua A, Smith D, Pochard P, et al. Exosome release of beta-catenin: A novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010; 190:1079-1091
56. Kaplan R, Riba R, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 2005; 438:820- 827
57. Iero M, Valenti R, Huber V, et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 2008; 15:80-88
58. Yu S, Liu C, Su K, et al. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 2007; 178:6867-6875
59. Xiang X, Poliakov A, Liu C, et al. Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer 2009; 124:2621-2633
60. Grange C, Tapparo M, Collino F, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 2011; 71:5346-5356
61. Millimaggi D, Mari M, D'Ascenzo S, et al. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 2007; 9:349-357
62. Castellana D, Zobairi F, Martinez M, et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: A role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 2009; 69:785-793
63. Wysoczynski M, Ratajczak M. Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors. Int J Cancer 2009; 125:1595-1603
64. Sidhu S, Mengistab A, Tauscher A, et al. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 2004; 23:956-963
65. Hood J, San R, Wickline S. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 2011; 71:3792- 3801
66. Ben-Baruch A. Site-specific metastasis formation: Chemokines as regulators of tumor cell adhesion, motility and invasion. Cell Adhes Migr 2009; 3:328- 333
67. Cai Z, Yang F, Yu L, et al. Activated T cell exosomes promote tumor invasion via Fas signaling pathway. J Immunol 2012; 188:5954-5961
68. Bayley J, Devilee P. The Warburg effect in 2012. Curr Opin Oncol 2012; 24:62-67
69. Gutwein P, Stoeck A, Riedle S, et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res 2005; 11:2492-2501
70. Park J, Tan H, Datta A, et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 2010; 9:1085-1099
71. Hedlund M, Nagaeva O, Kargl D, et al. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One 2011; 6:e16899
72. Chen T, Guo J, Yang M, et al. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol 2011; 186:2219-2228
73. Bausero M, Gastpar R, Multhoff G, Asea A. Alternative mechanism by which IFN-gamma enhances tumor recognition: Active release of heat shock protein 72. J Immunol 2005; 175:2900-2912
74. Klionsky D. Autophagy: From phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8:931-937
75. Wu W, Coffelt S, Cho C, et al. The autophagic paradox in cancer therapy. Oncogene 2012; 31:939-953
76. Fader C, Colombo M. Autophagy and multivesicular bodies: Two closely related partners. Cell Death Differ 2009; 16:70-78
77. Fader C, Sanchez D, Furlan M, Colombo M. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic 2008; 9:230-250
78. Hainaut P, Wiman K. 30 years and a long way into p53 research. Lancet Oncol 2009; 10:913-919
79. Lespagnol A, Duflaut D, Beekman C, et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 2008; 15:1723- 1733
80. D'Souza-Schorey C, Clancy J. Tumor-derived microvesicles: Shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012; 26:1287-1299
81. Koga K, Matsumoto K, Akiyoshi T, et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 2005; 25:3703-3707
82. Baran J, Baj-Krzyworzeka M, Weglarczyk K, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010; 59:841-850
83. Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009; 4:e5219
84. Houali K, Wang X, Shimizu Y, et al. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res 2007; 13:4993-5000
85. Li Y, Zhang Y, Qiu F, Qiu Z. Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC. Electrophoresis 2011; 32:1976-1983
86. Hessels D, Smit F, Verhaegh G, et al. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 2007; 13:5103- 5108
87. Nilsson J, Skog J, Nordstrand A, et al. Prostate cancer-derived urine exosomes: A novel approach to biomarkers for prostate cancer. Br J Cancer 2009; 100:1603-1607
88. Lu Q, Zhang J, Allison R, et al. Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate 2009; 69:411-418
89. Bryant R, Pawlowski T, Catto J, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012; 106:768-774
90. Runz S, Keller S, Rupp C, et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 2007; 107:563-571
91. Li J, Sherman-Baust C, Tsai-Turton M, et al. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 2009; 9:244
92. Taylor D, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110:13- 21
93. Ronquist K, Ronquist G, Larsson A, Carlsson L. Proteomic analysis of prostate cancer metastasis-derived prostasomes. Anticancer Res 2010; 30:285-290
94. Silva J, Garcia V, Rodriguez M, et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 2012; 51:409-418
95. Arscott W, Camphausen K. EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. Biomark Med 2011; 5:821.